As of November 2024, FibroGen has a market cap of $44.07M. This makes FibroGen the world's 25910th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $207.74M | 138.43% |
2023 | $87.13M | -94.47% |
2022 | $1.58B | 13.62% |
2021 | $1.39B | -61.98% |
2020 | $3.65B | -13.52% |
2019 | $4.22B | -7.32% |
2018 | $4.55B | -2.36% |
2017 | $4.66B | 121.50% |
2016 | $2.10B | -29.77% |
2015 | $3.00B | 11.45% |
2014 | $2.69B | - |